Eligo Raises $30 Million To Write a Novel Chapter for Genetic Medicines
05 Dec 2023 //
BUSINESSWIRE
Eligo Bioscience Receives FDA ODD and RPD Designation for EB003
11 Oct 2022 //
PRNEWSWIRE
Eligo Bioscience Announces Successful Outcome in US Patent Interference
02 Dec 2021 //
PRNEWSWIRE